RH+N-KLINIKUM Aktiengesellschaft reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was EUR 363.9 million compared to EUR 346.9 million a year ago. Revenue was EUR 419.88 million compared to EUR 393.92 million a year ago. Net income was EUR 10.52 million compared to EUR 6.94 million a year ago. Basic earnings per share from continuing operations was EUR 0.16 compared to EUR 0.1 a year ago. Diluted earnings per share from continuing operations was EUR 0.16 compared to EUR 0.1 a year ago.
For the six months, sales was EUR 711.19 million compared to EUR 682.8 million a year ago. Revenue was EUR 817.63 million compared to EUR 777.58 million a year ago. Net income was EUR 11.52 million compared to EUR 8.06 million a year ago. Basic earnings per share from continuing operations was EUR 0.17 compared to EUR 0.12 a year ago. Diluted earnings per share from continuing operations was EUR 0.17 compared to EUR 0.12 a year ago.